GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RAMM Pharma Corp (XCNQ:RAMM) » Definitions » Scaled Net Operating Assets

RAMM Pharma (XCNQ:RAMM) Scaled Net Operating Assets : 0.47 (As of Oct. 2024)


View and export this data going back to 2019. Start your Free Trial

What is RAMM Pharma Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

RAMM Pharma's operating assets for the quarter that ended in Oct. 2024 was C$15.94 Mil. RAMM Pharma's operating liabilities for the quarter that ended in Oct. 2024 was C$2.93 Mil. RAMM Pharma's Total Assets for the quarter that ended in Jul. 2024 was C$27.41 Mil. Therefore, RAMM Pharma's scaled net operating assets (SNOA) for the quarter that ended in Oct. 2024 was 0.47.


RAMM Pharma Scaled Net Operating Assets Historical Data

The historical data trend for RAMM Pharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RAMM Pharma Scaled Net Operating Assets Chart

RAMM Pharma Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.19 1.06 0.44 0.63 0.40

RAMM Pharma Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.75 0.79 0.84 0.48

Competitive Comparison of RAMM Pharma's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, RAMM Pharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RAMM Pharma's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RAMM Pharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where RAMM Pharma's Scaled Net Operating Assets falls into.


;
;

RAMM Pharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

RAMM Pharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Oct. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Oct. 2024 )
=(Operating Assets (A: Oct. 2024 )-Operating Liabilities (A: Oct. 2024 ))/Total Assets (A: Oct. 2023 )
=(15.935-2.926)/32.3
=0.40

where

Operating Assets(A: Oct. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=16.749 - 0.814
=15.935

Operating Liabilities(A: Oct. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3.114 - 0.085 - 0.103
=2.926

RAMM Pharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Oct. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Oct. 2024 )
=(Operating Assets (Q: Oct. 2024 )-Operating Liabilities (Q: Oct. 2024 ))/Total Assets (Q: Jul. 2024 )
=(15.935-2.926)/27.41
=0.47

where

Operating Assets(Q: Oct. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=16.749 - 0.814
=15.935

Operating Liabilities(Q: Oct. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3.114 - 0.085 - 0.103
=2.926

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RAMM Pharma Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of RAMM Pharma's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


RAMM Pharma Business Description

Traded in Other Exchanges
N/A
Address
82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue primarily from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of revenue from Uruguay.
Executives
Jackie Peter Burnett 10% Security Holder, Director, Senior Officer
Armando Gabriel Blankleider Director

RAMM Pharma Headlines

No Headlines